Glycolysis links p53 function with NF-κB signaling: Impact on cancer and aging process

Journal of Cellular Physiology

Volumn 224, Issue 1, 2010, Pages 1-6

  Salminen, Antero ^a,b   Kaarniranta, Kai ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OXYGEN RADICAL; PROTEIN P53; I KAPPA B KINASE;

AEROBIC METABOLISM; AGING; CANCER CELL; CATALYST; ENERGY METABOLISM; ENERGY YIELD; GLYCOLYSIS; GLYCOSYLATION; MITOCHONDRIAL RESPIRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SHORT SURVEY; ANIMAL; HUMAN; METABOLISM; NEOPLASM; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION;

AGING; ANIMALS; GLYCOLYSIS; GLYCOSYLATION; HUMANS; I-KAPPA B KINASE; NEOPLASMS; NF-KAPPA B; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77952509221     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22119     Document Type: Short Survey

References (91)

1. Adler AS, Sinha S, Kawahara TLA, Zhang JY, Segal E, Chang HY. 2007. Motif module map reveals enforcement of aging by continual NF-κB activity. Genes Dev 21:3244-3257.
2. Almeida A, Moncada S, Bolanos JP. 2004. Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructo-2-kinase pathway. Nat Cell Biol 6:45-51.
3. Ames BN, Shigenaga MK, Hagen TM. 1995. Mitochondrial decay in aging. Biochim Biophys Acta 1271:165-170.
4. Andrews ZB, Horvath TL. 2009. Uncoupling protein-2 regulates lifespan in mice. Am J Physiol Endocrinol Metab 296:E621-E627.
5. Apfeld J, O'Connor G, McDonagh T, DiStefano PS, Curtis R. 2004. The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans. Genes Dev 18:3004-3009.
6. Atsumi T, Cho YR, Leng L, McDonald C, Yu T, Danton C, Hong EG, Mitchell RA, Metz C, Niwa H, Takeuchi J, Onodera S, Umino T, Yoshioka N, Koike T, Kim JK, Bucala R. 2007. The proinflammatory cytokine macrophage migration inhibitory factor regulates glucose metabolism during systemic inflammation. J Immunol 179:5399-5406.
7. Bauer DE, Harris MH, Plas DR, Lum JJ, Hammerman PS, Rathmell JC, Riley JL, Thompson CB. 2004. Cytokine stimulation of aerobic glycolysis in hematopoietic cells exceeds proliferative demand. FASEB J 18:1303-1305.
8. Beckman KB, Ames BN. 1998. The free radical theory of aging matures. Physiol Rev 78:547-581. (Pubitemid 28182903)
9. Bell EL, Klimova TA, Eisenbart J, Schumacker PT, Chandel NS. 2007. Mitochondrial reactive oxygen species trigger hypoxia-inducible factor-dependent extension of the replicative life span during hypoxia. Mol Cell Biol 27:5737-5745.
10. Benigni F, Atsumi T, Calandra T, Metz C, Echtenacher B, Peng T, Bucala R. 2000. The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism in muscle. J Clin Invest 106:1291-1300.
11. Bensaad K, Vousden KH. 2007. p53: New roles in metabolism. Trends Cell Biol 17:286-291.
12. Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R, Gottlieb E, Vousden KH. 2006. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126:107-120.
13. Brahimi-Horn MC, Chiche J, Pouyssegur J. 2007. Hypoxia signalling controls metabolic demand. Curr Opin Cell Biol 19:223-229.
14. Brand KA, Hermfisse U. 1997. Aerobic glycolysis by proliferating cells: A protective strategy against reactive oxygen species. FASEB J 11:388-395. (Pubitemid 27193945)
15. Campisi J. 2005. Senescent cells, tumor suppression, and organismal aging: Good citizens, bad neighbors. Cell 120:513-522.
16. Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC, Schumacker PT. 1998. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci USA 95:11715-11720.
17. Crighton D, Wilkinson S, O'Prey J, Syed N, Smith P, Harrison PR, Gasco M, Garrone O, Crook T, Ryan KM. 2006. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 126:121-134.
18. Curtis R, O'Connor G, DiStefano PS. 2006. Aging networks in Caenorhabditis elegans: AMP-activated protein kinase (aak-2) links multiple aging and metabolism pathways. Aging Cell 5:119-126.
19. De Magalhaes JP, Curado J, Church GM. 2009. Meta-analysis of age-related gene expression profiles identifies common signatures of aging. Bioinformatics 25:875-881.
20. El-Hassan A, Zubairu S, Hothersall JS, Greenbaum AL. 1981. Age-related changes in enzymes of rat brain. 1. Enzymes of glycolysis, the pentose phosphate pathway and lipogenesis. Enzyme 26:107-112.
21. Feng Z, Hu W, Teresky AK, Hernando E, Cordon-Cardo C, Levine AJ. 2007. Declining p53 function in the aging process: A possible mechanism for the increased tumor incidence in older populations. Proc Natl Acad Sci USA 104:16633-16638.
22. Finkel T, Serrano M, Blasco MA. 2007. The common biology of cancer and ageing. Nature 448:767-774.
23. Fulop N, Feng W, Xing D, He K, Not LG, Brocks CA, Marchase RB, Miller AP, Chatham JC. 2008. Aging leads to increased levels of protein O-linked N-acetylglucosamine in heart, aorta, brain and skeletal muscle in Brown-Norway rats. Biogerontology 9:139-151.
24. Gladden LB. 2004. Lactate metabolism: A new paradigm for the third millennium. J Physiol 558:5-30.
25. Gloire G, Legrand-Poels S, Piette J. 2006. NF-κB activation by reactive oxygen species: Fifteen years later. Biochem Pharmacol 72:1493-1505.
26. Gogvadze V, Orrenius S, Zhivotovsky B. 2008. Mitochondria in cancer cells: What is so special about them? Trends Cell Biol 18:165-173.
27. Green D, Kroemer G. 2009. Cytoplasmic functions of the tumour suppressor p53. Nature 458:1127-1130.
28. Greer EL, Oskoui PR, Banko MR, Maniar JM, Gygi MP, Gygi SP, Brunet A. 2007. The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J Biol Chem 282:30107-30119.
29. Gross DN, van den Heuvel APJ, Birnbaum MJ. 2008. The role of FoxO in the regulation of metabolism. Oncogene 27:2320-2336.
30. Guarente L. 2008. Mitochondria - A nexus for aging, caloric restriction, and sirtuins? Cell 132:171-176.
31. Hagopian K, Ramsey JJ, Weindruch R. 2003. Influence of age and caloric restriction on liver glycolytic enzyme activities and metabolite concentrations in mice. Exp Gerontol 38:253-266.
32. Harman D. 1956. Aging: A theory based on free radical and radiation chemistry. J Gerontol 11:298-300.
33. Helenius M, Hanninen M, Lehtinen SK, Salminen A. 1996. Changes associated with aging and replicative senescence in the regulation of transcription factor nuclear factor-κB. Biochem J 318:603-608. (Pubitemid 26305964)
34. Hipkiss AR. 2006. On the mechanism of ageing suppression by dietary restriction - Is persistent glycolysis the problem? Mech Age Dev 127:8-15.
35. Ho HY, Cheng ML, Chiu DT. 2007. Glucose-6-phosphate dehydrogenase - From oxidative stress to cellular functions and degenerative diseases. Redox Rep 12:109-118.
36. Holt SJ, Riddle DL. 2003. SAGE surveys C. elegans carbohydrate metabolism: Evidence for an anaerobic shift in the long-lived dauer larva. Mech Age Dev 124:779-800.
37. Housley MP, Rodgers JT, Udeshi ND, Kelly TJ, Shabanowitz J, Hunt DF, Puigserver P, Hart GW. 2008. O-GlcNAc regulates FoxO activation in response to glucose. J Biol Chem 283:16283-16292.
38. Huang LE. 2008. Carrot and stick: HIF-a engages c-Myc in hypoxic adaptation. Cell Death Differ 15:672-677.
39. Hulbert AJ, Pamplona R, Buffenstein R, Buttemer WA. 2007. Life and death: Metabolic rate, membrane composition, and life span of animals. Physiol Rev 87:1175-1213.
40. Hunt ND, Hyun DH, Allard JS, Minor RK, Mattson MP, Ingram DK, de Cabo R. 2006. Bioenergetics of aging and caloric restriction. Ageing Res Rev 5:125-143.
41. Ingram DK, Zhu M, Mamczarz J, Zou S, Lane MA, Roth GS, de Cabo R. 2006. Calorie restriction mimetics: An emerging research field. Aging Cell 5:97-108. (Pubitemid 44056501)
42. Jones RG, Pias DR, Kubek S, Buzzai M, Mu J, Xu Y, Birnbaum MJ, Thompson CB. 2005. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 18:283-293.
43. Jung H, Seong HA, Ha H. 2008. Critical role of cysteine residue 81 of macrophage migration inhibitory factor (MIF) in MIF-induced inhibition of p53 activity. J Biol Chem 283:20383-20396.
44. Karin M. 2008. The IκB kinase - Abridge between inflammation and cancer. Cell Res 18:334-342.
45. Kawahara TL, Michishita E, Adler AS, Damian M, Berber E, Lin M, McCord RA, Ongaigui KC, Boxer LD, Chang HY, Chua KF. 2009. SIRT6 links histone H3 lysine 9 deacetylation to NFκB-dependent gene expression and organismal life span. Cell 136:62-74.
46. Kawauchi K, Araki K, Tobiume K, Tanaka N. 2008. p53 Regulates glucose metabolism through an IKK-NF-κB pathway and inhibits cell transformation. Nat Cell Biol 10:611-618.
47. Kawauchi K, Araki K, Tobiume K, Tanaka N. 2009. Loss of p53 enhances catalytic activity of IKKβ through O-linked β-N-acetyl glucosamine modification. Proc Natl Acad Sci USA 106:3431-3436.
48. Lee SS, Lee RY, Frazer AG, Kamath RS, Ahringer J, Ruvkun G. 2003. A systematic RNAi screen identifies a critical role for mitochondria in C. elegans longevity. Nature Genet 33:40-48.
49. Lemire BD, Behrendt M, De Corby A, Gaskova D. 2009. C. elegans longevity pathways converge to decrease mitochondrial membrane potential. Mech Ageing Dev 130:461-465.
50. Lesnefsky EJ, Hoppel CL. 2006. Oxidative phosphorylation and ageing. Ageing Res Rev 5:402-433.
51. Li Q, Withoff S, Verma IM. 2005. Inflammation-associated cancer: NF-κB is the lynchpin. Trends Immunol 26:318-325.
52. Longo VD, Kennedy BK. 2006. Sirtuins in aging and age-related disease Cell. 126:257-268.
53. Madi A, Mikkat S, Koy C, Ringel B, Thiesen HJ, Glocker MO. 2008. Mass spectrometric proteome analysis suggests anaerobic shift in metabolism of dauer larvae of Caenorhabditis elegans. Biochim Biophys Acta 1784:1763-1770.
54. Mathupala SP, Ko YH, Pedersen PL. 2009. Hexokinase-2 bound to mitochondria: Cancer's stygian link to the "Warburg effect" and a pivotal target for effective therapy. Semin Cancer Biol 19:17-24.
55. Mendrysa SM,O'Leary KA, McElwee MK, Michalowski J, Eisenman RN, Powell DA, Perry ME. 2006. Tumor suppression and normal aging in mice with constitutively high p53 activity. Genes Dev 20:16-21.
56. Moore L, Lu X, Ghebranious N, Tyner S, Donehower LA. 2007. Aging-associated truncated form of p53 interacts with wild-type p53 and alters p53 stability, localization, and activity. Mech Ageing Dev 128:717-730.
57. Navarro A, Boveris A. 2007. The mitochondrial energy transduction system and the ageing process. Am J Physiol Cell Physiol 292:C670-C686.
58. Olovnikov IA, Kravchenko JE, Chumakov PM. 2009. Homeostatic functions of the p53 tumor suppressor: Regulation of energy metabolism and antioxidant defence. Semin Cancer Biol 19:32-41.
59. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC. 2006. HIF-1 mediates adaptation to hypoxia by actively downregulatingmitochondrial oxygen consumption. Cell Metab 3:187-197.
60. Papazoglu C, Mills AA. 2007. p53: At the crossroad between cancer and ageing. J Pathol 211:124-133.
61. Pedersen PL. 2007. Warburg, me and hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotype, the "Warburg effect," i.e. elevated glycolysis in the presence of oxygen. J Bioenergy Biomembr 39:211-222.
62. Perkins ND. 2004. NF-κB: Tumor promoter or suppressor? Trends Cell Biol 14:64-69.
63. Philp A, Macdonald AL, Watt PW. 2005. Lactate - A signal coordinating cell and systemic functions. J Exp Biol 208:4561-4575.
64. Prahl S, Kueper T, Biernoth T, Wohrmann Y, Münster A, Furstenau M, Schmidt M, Schulze C, Wittern KP, Wenck H, Muhr GM, Blatt T. 2008. Aging skin is functionally anaerobic: Importance of coenzyme Q10 for anti aging skin care. Biofactors 32:245-255.
65. Renner F, Schmitz ML. 2008. Autoregulatory feedback loops terminating the NF-κB response. Trends Biochem Sci 34:128-135.
66. Robey RB, Hay N. 2009. Is Akt the "Warburg kinase"? Akt-energy metabolism interactions and oncogenesis. Semin Cancer Biol 19:25-31.
67. Rodier F, Campisi J, Bhaumik D. 2007. Two faces of p53: Aging and tumor suppression. Nucleic Acid Res 35:7475-7484.
68. Salminen A, Kaarniranta K. 2009a. NF-κB signaling in the aging process. J Clin Immunol 29:397-405.
69. Salminen A, Kaarniranta K. 2009b. Regulation of the aging process by autophagy. Trends Mol Med 15:217-224.
70. Salminen A, Ojala J, Huuskonen J, Kauppinen A, Suuronen T, Kaarniranta K. 2008. Interaction of aging-associated signaling cascades: Inhibition of NF-κB signaling by longevity factors FoxOs and SIRT1. Cell Mol Life Sci 65:1049-1058.
71. Semenza GL. 2009. Regulation of cancer cell metabolism by hypoxia-inducible factor 1. Semin Cancer Biol 19:12-16.
72. Spencer NF, Poynter ME, Im SY, Daynes RA. 1997. Constitutive activation of NF-κB in an animal model of aging. Int Immunol 9:1581-1588.
73. Tergaonkar V, Perkins ND. 2007. p53 and NF-κB crosstalk: IKKa tips the balance. Mol Cell 26:158-159.
74. Terman A, Brunk UT. 2006. Oxidative stress, accumulation of biological 'carbage' and aging. Antioxid Redox Signal 8:197-204.
75. Towler MC, Hardie DG. 2007. AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res 100:328-341.
76. Trifunovic A, Larsson NG. 2008. Mitochondrial dysfunction as a cause of ageing. J Int Med 263:167-178.
77. Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE, Bohlooly-Y M, Gidlöf S, Oldfors A, Wibom R, Törnell J, Jacobs HT, Larsson NG. 2004. Premature ageing in mice expressing defective mitochondrial DNA polymerase.Nature 429:417-423.
78. Tsang WY, Lemire BD. 2003. The role of mitochondria in the life of the nematode, Caenorhabditis elegans. Biochim Biophys Acta 1638:91-105.
79. Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, Igelmann H, Lu X, Soron G, Cooper B, Brayton C, Hee Park S, Thompson T, Karsenty G, Bradley A, Donehower LA. 2002. p53 Mutantmice that display early ageing-associated phenotypes.Nature 415:45-53.
80. Van der Horst A, Burgering BMT. 2007. Stressing the role of FoxO proteins in lifespan and disease. Nat Rev Mol Cell Biol 8:440-450.
81. Van Uden P, Kenneth NS, Rocha S. 2008. Regulation of hypoxia-inducible factor-1α by NF-κB. Biochem J 412:477-484.
82. Vousden KH, Ryan KM. 2009. p53 and metabolism. Nature Rev Cancer 9:691-700.
83. Wojtczak L. 1996. The Crabtree effect: A new look at the old problem. Acta Biochim Pol 43:361-368. (Pubitemid 126417438)
84. Wolkow CA, Iser WB. 2006. Uncoupling protein homologs may provide a link between mitochondria, metabolism and lifespan. Ageing Res Rev 5:196-208.
85. Yamaza H, Chiba T, Higami Y, Shimokawa I. 2002. Lifespan extension by caloric restriction: An aspect of energy metabolism. Microsc Res Techn 59:325-330.
86. Yang WH, Kim JE, Nam HW, Ju JW, Kim HS, Kim YS, Cho JW. 2006. Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. Nat Cell Biol 8:1074-1083.
87. Yang WH, Park SY, Nam HW, Kim do H, Kang JG, Kang ES, Kim YS, Lee HC, Kim KS, Cho JW. 2008. NFκB activation is associated with its O-GlcNAcylation state under hyperglycemic conditions. Proc Natl Acad Sci USA 105:17345-17350.
88. Yeung SJ, Pan J, Lee MH. 2008. Roles of p53, Myc and HIF-1 in regulating glycolysis - The seventh hallmark of cancer. Cell Mol Life Sci 65:3981-3999.
89. Zachara NE, Hart GW.2006. Cell signaling, the essential role of O-GlcNAc! Biochim Biophys Acta 1761:599-617.
90. Zentella A, Manogue K, Cerami A. 1993. Cachectin/TNF-mediated lactate production in cultured myocytes is linked to activation of a futile substrate cycle. Cytokine 5:436-447.
91. Zhou Q, Lam PY, Han D, Cadenas E. 2009. Activation of c-Jun-N-terminal kinase and decline of mitochondrial pyruvate dehydrogenase activity during brain aging. FEBS Lett 583:1132-1140.